HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Fmr LLC

Fmr LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.7% in the third quarter, Holdings Channel.com reports. The fund owned 5,290,116 shares of the company’s stock after selling 39,723 shares during the quarter. Fmr LLC owned approximately 0.06% of HealthEquity worth $432,996,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. GSA Capital Partners LLP acquired a new stake in shares of HealthEquity in the third quarter valued at about $638,000. Vaughan Nelson Investment Management L.P. boosted its stake in shares of HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Natixis Advisors LLC grew its holdings in shares of HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after acquiring an additional 48,009 shares during the period. Oppenheimer Asset Management Inc. increased its stake in HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock valued at $5,535,000 after purchasing an additional 14,573 shares in the last quarter. Finally, Diversify Wealth Management LLC purchased a new stake in HealthEquity during the second quarter worth $8,182,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have recently weighed in on HQY shares. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, JMP Securities reiterated a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $107.23.

HealthEquity Price Performance

HQY stock opened at $101.54 on Friday. The stock has a market capitalization of $8.87 billion, a price-to-earnings ratio of 84.62, a price-to-earnings-growth ratio of 1.60 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $105.82. The stock’s fifty day simple moving average is $89.72 and its 200-day simple moving average is $82.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. Equities research analysts expect that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Activity at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.